Recruiting
Phase 1

A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors

Sponsor:

NiKang Therapeutics, Inc.

Code:

NCT06586957

Conditions

Solid Tumor

Advanced Solid Tumor

Solid Tumor, Adult

Metastatic Tumor

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NKT3964

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information